NancyChanMD

Oncology • New York, NY

Breast Cancer

Director, Breast Cancer Clinical Research

Join to view full profile

Dr. Chan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chan's full profile

Already have an account?

Office
160 E 34th St
New York, NY 10016
Phone+1 212-731-5349

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2011 - 2014
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2008 - 2011
Stony Brook University Health Sciences Center School of MedicineClass of 2008

Certifications & Licensure

NY State Medical License 2011 - 2026
NJ State Medical License 2014 - 2025

Publications & Presentations

PubMed

Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Petros Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal
Clinical Cancer Research. 2024-10-15
1 citations
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receivi...
Joyce F Liu, Niya Xiong, Robert M Wenham, Andrea Wahner-Hendrickson, Deborah K Armstrong
Gynecologic Oncology. 2024-08-01
2 citations
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.
Kristen R Spencer, Daniella E Portal, Joseph Aisner, Mark N Stein, Jyoti Malhotra
Oncotarget. 2023-04-10

Lectures

A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

Breast Cancer Requires Surgery, Right? Not so FastDecember 17th, 2024
Perlmutter Cancer Center Medical Oncologist Advances Innovative Clinical Trials for Breast CancerFebruary 23rd, 2022
New Hope on the Horizon for Triple-Negative Breast Cancer Patients: Cleveland Clinic Launches Phase 1 Clinical Trial for TNBC VaccineOctober 26th, 2021
Join now to see all